The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain

Neuroscience Letters

Volumn 212, Issue 3, 1996, Pages 163-166

  Eastwood, Sharon L ^a,b   Porter, Richard H P ^a,b,c   Harrison, Paul J ^a,b  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c Cerebrus Limited   (United Kingdom)

Author keywords

( ) Amino 3 hydroxy 5 methylisoxazole 4 propionic acid receptor; Antipsychotic; In situ hybridization; Kainate receptor; N Methyl D aspartate receptor; Neuroleptic

Indexed keywords

GLUTAMATE RECEPTOR; HALOPERIDOL; HALOPERIDOL DECANOATE; KAINIC ACID RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030593497     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12801-9     Document Type: Article

References (26)

1. [1] Calabresi, P., De Murtas, M., Mercuri, N.B. and Bernardi, G., Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission, Ann. Neurol., 31 (1992) 366-373.
2. [2] Carlsson, M. and Carlsson, A., Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease, Trends Neurosci., 13 (1990) 272-276.
3. [3] DeKeyser, J., Excitotoxic mechanisms may be involved in the pathophysiology of tardive dyskinesia, Clin. Neuropharmacol., 14 (1991) 562-565.
4. [4] Eastwood, S.L., Story, P., Burnet, P.W.J., Heath, P. and Harrison, P.J., Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment, J. Psychopharmacol., 8 (1994) 196-203.
5. [5] Eastwood, S.L., McDonald, B., Burnet, P.W.J., Beckwith, J.P., Kerwin, R.W. and Harrison P.J., Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia, Mol. Brain Res., 29 (1995) 211-223.
6. [6] Eastwood, S.L., Porter, R.H.P., Burnet, P.W.J., Kerwin, R.W. and Harrison, P.J., Non-NMDA glutamate receptor expression in schizophrenia, Schizophr. Res., 18 (1996) 174.
7. [7] Fitzgerald, L.W., Deutch, A., Gasic, G., Heinemann, S.F. and Nestler, E.F., Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs, J. Neurosci., 15 (1995) 2453-2461.
8. [8] Freed, W.S., Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects, Neurosci. Biobehav. Rev., 18 (1994) 111-120.
9. 2+ permeability of AMPA receptors in principal neurons and intemeurons in rat CNS, Neuron, 15 (1995) 193-204.
10. [10] Hollmann, M. and Heinemann, S., Cloned glutamate receptors, Annu. Rev. Neurosci., 17 (1994) 31-108.
11. [11] Johnson, A.E., Liminga, U., Liden, A., Lindefors, N., Gunne, L.M. and Wiesel, F.-A., Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain, Neuroscience, 63 (1994) 1003-1020.
12. [12] Kamphuis, W., De Rijk, T.C., Talamini, L.M. and Lopes da Silva, F.H., Rat hippocampal kindling induces changes in the glutamate receptor mRNA expression patterns in dentate granule neurons, Eur. J. Neurosci., 6 (1994) 1119-1127.
13. [13] Kamphuis, W., Hendriksen, H., Diegenbach, P.C. and Lopes da Silva, F.H., N-Methyl-D-aspartate and kainate receptor gene expression in hippocampal pyramidal and granular neurons in the kindling model of epileptogenesis, Neuroscience, 67 (1995) 551-559.
14. 3H]-acetylcholine from rat striatal slices, Neuroscience, 11 (1984) 205-210.
15. [15] Kumar, K.N., Babcock, K.K., Johnson, P.S., Chen, X., Eggeman, K.T. and Michaelis, E.K., Purification and pharmacological and immunochemical characterization of synaptic membrane proteins with ligand-binding properties of N-methyl-D-aspartate receptors, J. Biol. Chem., 269 (1994) 27384-27393.
16. [16] Martin, L.J., Blackstone, C.D., Levey, A.I., Huganir, R.L. and Price, D.L., AMPA glutamate receptor subunits are differentially distributed in rat brain, Neuroscience, 53 (1993) 327-338.
17. [17] Meshul, C.K., Stallbaumer, R.K., Taylor, B. and Janowsky, A., Haloperidol-induced morphological changes in striatum are associated with glutamate synapses, Brain Res., 648 (1994) 181-195.
18. [18] Oretti, R.G., Spurlock, G., Buckland, P.R. and McGuffin, P., Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains, Neurosci. Lett., 177 (1994) 39-43.
19. [19] Petralia, R.S. and Wenthold, R.J., Light and electron immunocy-tochemical localization of AMPA-selective glutamate receptors in the rat brain, J. Comp. Neurol., 318 (1992) 329-354.
20. [20] Pollard, H., Heron, A., Moreau, J., Ben-Ari, Y. and Khrestshatisky, M., Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia, Neuroscience, 57 (1993) 545-554.
21. [21] Porter, R.H.P., Burnet, P.W.J., Eastwood, S.L. and Harrison, P.J., Contrasting effects of electroconvulsive shock on mRNAs encoding the high affinity kainate receptor subunits (KA1 and KA2) and cyclophilin in the rat, Brain Res., 710 (1996) 97-102.
22. [22] See, R.E. and Chapman, M.A., Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats, Eur. J. Pharmacol., 263 (1994) 269-276.
23. [23] Sommer, B., Keinanen, K., Verdoorn, T.A., Wisden, W., Burnashev, N., Herb, A., Kohler, M., Takagi, T., Sakmann, B. and Seeburg, P.H., Flip and flop: a cell-specific functional switch in glutamate-operated channels, Science, 249 (1990) 1580-1585.
24. [24] Ulas, J., Nguyen, L. and Cotman, C.W., Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex, NeuroReport, 4 (1993) 1049-1051.
25. [25] Yamamoto, B.K. and Cooperman, M.A., Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations, J. Neurosci., 14 (1994) 4159-4166.
26. [26] Ziolkowska, B. and Hollt, V., The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum, Neurosci. Lett., 156 (1993) 39-42.